240 related articles for article (PubMed ID: 27318396)
1. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
[TBL] [Abstract][Full Text] [Related]
2. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
3. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843
[TBL] [Abstract][Full Text] [Related]
4. Low rates of eligibility for lung cancer screening in patients undergoing computed tomography coronary angiography.
Lyne C; Zaw S; King B; See K; Manners D; Al-Kaisey A; Joshi S; Farouque O; Irving L; Johnson D; Steinfort D
Intern Med J; 2018 Oct; 48(10):1265-1268. PubMed ID: 30288901
[TBL] [Abstract][Full Text] [Related]
5. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
[TBL] [Abstract][Full Text] [Related]
6. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
[TBL] [Abstract][Full Text] [Related]
7. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
Tammemägi MC; Cina K; Kitts AKB; Koop D; Petereit MA; Sargent M; Petereit DG
Cancer; 2023 Dec; 129(24):3894-3904. PubMed ID: 37807694
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data.
Hüsing A; Kaaks R
Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286
[TBL] [Abstract][Full Text] [Related]
10. Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility.
Pu CY; Lusk CM; Neslund-Dudas C; Gadgeel S; Soubani AO; Schwartz AG
JAMA Oncol; 2022 Mar; 8(3):374-382. PubMed ID: 35024781
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
[TBL] [Abstract][Full Text] [Related]
12. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM
Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207
[TBL] [Abstract][Full Text] [Related]
13. Stratification and management of patients ineligible for lung cancer screening.
Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G
Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria.
Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH
Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946
[No Abstract] [Full Text] [Related]
15. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates.
Pinsky PF; Lau YK; Doubeni CA
Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164
[TBL] [Abstract][Full Text] [Related]
16. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.
Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A
Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378
[TBL] [Abstract][Full Text] [Related]
17. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M;
PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.
Ten Haaf K; Bastani M; Cao P; Jeon J; Toumazis I; Han SS; Plevritis SK; Blom EF; Kong CY; Tammemägi MC; Feuer EJ; Meza R; de Koning HJ
J Natl Cancer Inst; 2020 May; 112(5):466-479. PubMed ID: 31566216
[TBL] [Abstract][Full Text] [Related]
19. Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.
Williams RM; Kareff SA; Sackstein P; Roy T; Luta G; Kim C; Taylor KL; Tammemägi MC
Lung Cancer; 2022 Jul; 169():55-60. PubMed ID: 35644087
[TBL] [Abstract][Full Text] [Related]
20. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
Choi E; Ding VY; Luo SJ; Ten Haaf K; Wu JT; Aredo JV; Wilkens LR; Freedman ND; Backhus LM; Leung AN; Meza R; Lui NS; Haiman CA; Park SL; Le Marchand L; Neal JW; Cheng I; Wakelee HA; Tammemägi MC; Han SS
JAMA Oncol; 2023 Dec; 9(12):1640-1648. PubMed ID: 37883107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
